Slc7s as modifiers of the p53 pathway and methods of use

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01) A61K 38/17 (2006.01) A61K 39/395 (2006.01) C12Q 1/02 (2006.01) C12Q 1/42 (2006.01) C12Q 1/48 (2006.01) C12Q 1/527 (2006.01) G01N 33/50 (2006.01) G01N 33/53 (2006.01) G01N 33/573 (2006.01) G01N 33/574 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2448282

Human SLC7 genes are identified as modulators of the p53 pathway, and thus are therapeutic targets for disorders associated with defective p53 function. Methods for identifying modulators of p53, comprising screening for agents that modulate the activity of SLC7 are provided.

L'invention concerne des gènes humains SLC7 identifiés comme étant des modulateurs de la voie p53 et, de ce fait, constituant des cibles thérapeutiques pour des troubles associés à une fonction défectueuse de p53. La présente invention concerne également des procédés permettant d'identifier des modulateurs de p53, lesquels procédés consistent à cribler des agents modulant l'activité des SLC7.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Slc7s as modifiers of the p53 pathway and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Slc7s as modifiers of the p53 pathway and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Slc7s as modifiers of the p53 pathway and methods of use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1704505

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.